Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications—a methodological review
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Paludan-Müller, Asger S.
Text and Data Mining valid from 2021-04-08
Version of Record valid from 2021-04-08
25 September 2020
1 March 2021
8 April 2021
The authors declare that they have no competing interests.